Intervention not reported
Unforeseen adverse effects · General public or any of its constituent groups (excluding groups comprising solely of people with mental ill health)
1 finding from 1 review
Adverse effects [3 months] · Children with otitis media with effusion
Summary of findings: intranasal steroids showed no clear difference in adverse effects [3 months] compared with control (low certainty).
1 finding from 1 review
Adverse effects [3 months] · Children with otitis media with effusion
1 finding from 1 review
Adverse effects: specific ‐ seizure · patients with psychosis‐induced aggression or agitation
It is very uncertain whether CHLORPROMAZINE changes adverse effects ‐ seizures compared with HALOPERIDOL (very low certainty).
1 finding from 1 review
Adverse effects (fall down) · aggressive behaviour in schizophrenia
It is very uncertain whether structured risk assessment changes adverse effects (fall down) compared with standard professional care (very low certainty).
1 finding from 1 review
Adverse effects: IOP spikes · people with open‐angle glaucoma
It is very uncertain whether laser trabeculoplasty changes adverse effects: IOP spikes compared with trabeculectomy (very low certainty).
1 finding from 1 review
RR 1.78
Studies not reported
Very low
Adverse effects: IOP spikes · people with open‐angle glaucoma
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Side effects or other adverse events · adults with chronic bronchitis or chronic obstructive pulmonary disease
Summary of findings table ‐ immunostimulant showed no clear difference in adverse events/side effects compared with placebo (high certainty).
1 finding from 1 review
Adverse effects (behaviour) · participants with epilepsy (BECTS)
Sulthiame showed no clear difference in adverse effects (behaviour) compared with levetiracetam (low certainty).
1 finding from 1 review
Adverse effects: leukopenia · SSNS in children
It is very uncertain whether mycophenolate mofetil changes adverse effects: leukopenia compared with levamisole (very low certainty).
1 finding from 1 review
Adverse effects: leucopenia · SSNS in children
Levamisole showed no clear difference in adverse effects: leucopenia compared with steroids or placebo or both, or no treatment (low certainty).
1 finding from 1 review
Adverse effects: leucopenia · SSNS in children
Levamisole showed no clear difference in adverse effects: leucopenia compared with cyclophosphamide (low certainty).
1 finding from 1 review
Adverse effects: leucopenia · SSNS in children
It is very uncertain whether alkylating agents changes adverse effects: leucopenia compared with cyclosporin (very low certainty).
1 finding from 1 review
Adverse effects – back pain · post‐caesarean pain
1 finding from 1 review
Somnolence · people with drug‐resistant focal epilepsy
Rufinamide probably leads to higher adverse effects: somnolence compared with placebo (moderate certainty).
1 finding from 1 review
Somnolence · patients between 3 to 15 months of age with West syndrome
It is very uncertain whether sulthiame add‐on changes adverse effects: somnolence compared with placebo (very low certainty).
1 finding from 1 review
Adverse effects (12 months) · patients with PTS
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects ‐ epistaxis · chronic rhinosinusitis
Topical antifungal showed no clear difference in adverse effects ‐ epistaxis compared with placebo/no treatment (low certainty).
1 finding from 1 review
RR 0.97 [0.14, 6.63]
Studies not reported
Low
Somnolence · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether dietary supplements (Catuama herbal compound) changes adverse effects: drowsiness compared with placebo (very low certainty).
1 finding from 1 review
Somnolence · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether benzodiazepines (topical clonazepam) changes adverse effects: drowsiness compared with placebo (very low certainty).
1 finding from 1 review